A. Dubanchet

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients

T. Lambert, M. Bertrand, V. Gay, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients with regular physical activity.

F. Carré, H. Douard, R. Brion, 2000, Journal of cardiovascular pharmacology.

A blinded in vitro study with Refacto® mock plasma samples: similar FVIII results between the chromogenic assay and a one‐stage assay when using a higher cephalin dilution

C. Rothschild, M. Dautzenberg, P. Pouzol, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one‐stage clotting assay

C. Ternisien, C. Caron, M. Aillaud, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study

M. Dougados, I. Logeart, F. Berenbaum, 2014, Arthritis Research & Therapy.

Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.

M. Safar, A. Benetos, S. Consoli, 2000, American Heart Journal.

Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis

M. Dougados, D. M. van der Heijde, I. Logeart, 2015, Journal of Rheumatology.

Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis

M. Dougados, D. M. van der Heijde, I. Logeart, 2015, The Journal of Rheumatology.